Skip to Content

How mission fuels risk-taking


The CEO of Illumina, Francis deSouza, has been locked in a multi-year battle with the FTC over the re-acquisition of a company it previously spun out, called GRAIL, that has a breakthrough cancer screening test. Talking with Bob Safian, deSouza reflects on the lessons of grappling with regulators, highlighting levers that can help to accelerate scale.